Monsenso signs two contracts with the Psychiatric Research Unit, Region West Zealand.

Monsenso signs two contracts with the Psychiatric Research Unit, Region West Zealand.

Monsenso signs two contracts with Research Unit for Psychotherapy and Psychopathology, Psychiatry West, Slagelse, Region Zealand Mental Health Services, who will use Monsenso’s digital health solution to remotely monitor patients with depression and schizotypal mental illness, respectively.

The first project, Development of an Intervention for Persistent Not on Track: DIP NOT, led by Jasmin Rejaye Gryesten, aims to identify non-responders to depression treatment, with the ultimate goal of increasing the number of remitted patients after CBT in the Danish MHS by developing a set of new person-centered add-on interventions to group CBT, to be used in case of observed lack of progress or deterioration.

The second project Phenomenologically informed PsychoTherapy for patients with Schizotypal Personality Disorder (PPT -SPD), is led by Kåre Donskov Nielsen and aims to develop and test new forms of phenomenological therapy that can help people with schizotypal mental illness.

About Monsenso digital health solution:
The Monsenso solution is a clinically validated, CE Class I Marked mHealth solution classified as a Medical Device, consisting of a smartphone app for patients and a clinical web portal for healthcare providers that are widely used in the prevention and treatment of common behavioural disorders such as depression and anxiety. It can also be configured to prevent and treat severe mental illnesses such as depression, bipolar disorder, borderline personality disorder, PTSD, and schizophrenia. It is currently being used by over 1,000 patients across the globe and is highly valued by patients and healthcare providers.

For additional information contact:

Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso

Improving the treatment of postpartum depression in teenage mothers

Improving the treatment of postpartum depression in teenage mothers

Postpartum depression (PPD) is a mood disorder that can affect women after giving birth, and the symptoms are similar to the ones presented in major depressive disorder. It is estimated that 10 to 15% of new adult mothers develop Postpartum Depression (PPD) within the first year after giving birth -and the percentage increases up to 26% in adolescent mothers. [1]

According to a survey published in 2012 by the Paediatrics journal, the highest incidence of postpartum depression occurs amongst girls aged 15 to 19, which is twice as high as their older counterparts. [2]

Why is that?

Adolescent mothers have to face more challenges than adult mothers. A teenage mother will suddenly face multiple changes in her life: she might have to quit school and be home-schooled instead, she might also need to get a job, and her social life will change drastically. Besides all of these changes, she will also become affected by a hormonal imbalance, which can lead to depression.

Due to all the hardship adolescent mothers have to cope with, they tend to rate their child’s health and their own as suboptimal. Besides, many young mothers are already under the stress of becoming new parents, which can also be linked to postpartum depression. [2]

Unfortunately, in most cases, PPD remains undiagnosed. The main problem is that it’s not always easy to distinguish baby blues from postpartum depression. Unlike baby blues, postpartum depression is a more severe problem that shouldn’t be ignored. While mothers who experience baby blues feel sorrow for the first two weeks after delivery, mothers who suffer from postpartum depression feel an overwhelming sadness or irritability a month after childbirth. Symptoms also include trouble eating and sleeping, difficulty concentrating, fatigue, loss of pleasure, reduced sex drive, and thoughts of suicide. [3]

The best treatment available for PPD is early intervention, since this condition is extremely responsive to treatment. Once the baby is born, family members can show their support towards young mothers by helping take care of the baby to help prevent postpartum depression. Besides, family members can also encourage her to seek help if she displays long periods of sadness and tearfulness.

A study at Women & Infants Hospital of Rhode Island found that an intervention program cut the incidence of postpartum depression in teenage mothers by 50%. [2]

The Monsenso mHealth solution can help identify PPD in young mothers at an early stage. Care providers could encourage new mothers to download the Monsenso app on their smartphones. The app will enable them to complete daily self-assessments in which they can rate themselves on relevant parameters such as their levels of stress, anxiety, tearfulness and the number of hours they slept. The Monsenso app makes it easier for adolescent mothers to reveal and share the current status of their mental health without feeling uncomfortable.

Furthermore, the Monsenso solution also enables healthcare professionals to monitor patients on a daily basis, and intervene when the system displays a patient presenting triggers or early warning signs. The clinical web portal also works as a two-way encrypted communication channel enabling patients and clinicians to always stay in touch.

References:

[1] The Environmental, Cultural, Relational and Physiological Aspects of Postpartum Depression. The Faculty of the Adler Graduate School. Joanne E. Campbell. 2010.
http://www.alfredadler.edu/sites/default/files/Campbell%20MP%202010.pdf

[2] The Mental Health of Teen Moms Matters. Diana Reese.
http://seleni.org/advice-support/article/the-mental-health-of-teen-moms-matters

[3] About Teenage Mothers & Depression. Michelle Bolyn. 2015.
http://www.livestrong.com/article/136548-about-teenage-mothers-depression/